OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Processing Equipment Trends
Data analytics, modular equipment, digital tools, and risk-based validation improve speed, flexibility, and quality.
Opportunities and developments in particle engineering are providing developers with the tools to advance drug candidates successfully.
Advancements in soft capsule technology can enable the development of soft capsule formulations.
Examining new approaches, novel technologies, and the structural evolution of the raw materials market.
Replacing a step in sample preparation with an automated approach improves both method precision and productivity.
Advancing OSD: Continuous Production Considerations and Dose-Level Authentication
December 05, 2022
In addition, personnel, equipment, and facilities from the acquired companies will expand Reaction Biology’s presence in Germany while enabling its global customers to leverage Bioassay’s expansive portfolio of regulated clinical and commercial services.
December 03, 2022
Overall industry growth conceals growing numbers of smaller, faster-paced, adaptable corporate structures.
Unique solutions are required to protect inherently unstable messenger RNA.
Although well known in R&D, PK/PD studies are an equally powerful tool for promoting successful biologic drug development.
QMM is an evolutionary advancement in FDA’s quality management maturity initiative that provides industry with a viable methodology to assess and improve manufacturing quality and supply chain reliability.
December 02, 2022
Pharmaceutical Technology Europe got the scoop on Agilent's new Dissolution Testing Centre of Excellence in Craven Arms, UK.
Dissolution testing is experiencing a refresh thanks to a variety of market drivers.
The European Human Medicines Directive and Regulation is due to be updated by the end of 2022, but what changes are on the cards?
Anti-obesity drugs have the potential to be the next blockbusters, according to market analysis.
Health crises, political tension, and budget concerns were major challenges.